MIRA
INFORM REPORT
|
Report Date : |
10.06.2014 |
IDENTIFICATION DETAILS
|
Name : |
FRESENIUS MEDICAL CARE INDIA PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
S-21, 2nd Floor, Star City, District Centre, Mayur Place,
Mayur Vihar, Phase-1, New Delhi-110091 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2013 |
|
|
|
|
Date of
Incorporation : |
13.03.2006 |
|
|
|
|
Com. Reg. No.: |
55-147436 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs. 97.191 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24231DL2006FTC147436 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
DELF03117C |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACF9636N |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Trader of dialysis products |
|
|
|
|
No. of Employees
: |
150 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (47) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 1400000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having satisfactory track record. General financial position of the company seems to be sound and healthy.
Profitability of the company is fair. Trade relations are fair. Business is active. Payment terms are
reported to be usually correct. The company can be considered for business dealings at usual trade
terms and condition. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2014
|
Country Name |
Previous Rating (31.12.2013) |
Current Rating (31.03.2014) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INDIAN ECONOMIC OVERVIEW
US investment bank
Goldman Sachs has upgraded its outlook on Indian markets as it expects
positive impact of the election cycle.
India’s economy may
grow 4.7 % in the current financial year, lower than the official estimate of 4.9
%, Fitch Rating said. The global rating agency expects the economy to pick up
in the next two financial years.
Global ratings
agency Standard & Poor said increasing focus by India Inc on lowering debt
is likely to improve their credit profiles.
Singapore (1.1
million Indian tourists in 2012), Thailand (one million), the United Arab
Emirates ().98 million) and Malaysia ().82 million) emerged as the preferred
holidays hotspots for Indians. The total figure is expected to increase to 1.93
million by 2017, according to the latest Eurmonitor international report.
There is a $29.34 bn
outward foreign direct investment by domestic companies between April and
January of 2013/14 which has seen some signs of recovery according to a Care
Ratings report.
There are 264 number
of new companies being set up every day on average during 2014. Most of them
are registered in Mumbai. India had 1.38 million registered companies at the
end of January, 2014.
Twitter like
messaging service Weibo Corporation has filed to raise $ 500 million via a US
initial public offering. Alibaba, which owns a stake in Weibo is expected to
raise about $ 15 billion New York this year in the highest profile Internet IPO
since Facebook’s in 2012.
Bharti Airtel has
raised Rs.2,453.2 crore (350 million Swiss Francs) by selling six-year bonds at
a coupon rate of three per cent and maturing in 2020. This is the largest ever
bond offering by an Indian company in Swiss Francs. Bharat Petroleum
Corporation raised 175 million Swiss Francs by selling five year bonds at 2.98
% coupon rate in February.
Indian Oil
Corporation plans to invest Rs 7650 crore in setting up a petrochemical complex
at its almost complete Paradip refinery in Odhisha in three to four years. The
company board is set to consider the setting up of a 700000 tonne per annum
polypropylene plant at an estimated cost at Rs.3150 crore.
Global chief
information officers at gathering in Bangalore in April to meet Indian startups
at an event called Tech50 Watchout for Little Eye Labs-Facebook type deals in
the making.
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
INFORMATION PARTED BY
|
Name : |
Mr. Ashwani Rohilla |
|
Designation : |
Finished Department |
|
Contact No.: |
91-11-45509500 |
|
Date : |
09.06.2014 |
LOCATIONS
|
Registered Office : |
S-21, 2nd Floor, Star City, District Centre, Mayur Place,
Mayur Vihar, Phase-1, New Delhi-110091 |
|
Tel. No.: |
91-11-45509500 |
|
Fax No.: |
91-11-45509506 |
|
E-Mail : |
|
|
Location : |
Owned |
|
|
|
|
Branch Office Mumbai : |
B-307, Everest Grade, Mahkali Caves Road, Andheri (East),
Mumbai-400093, Maharashtra, India |
|
Tel. No.: |
91-22-42176500 |
|
Telefax No.: |
91-22-42176501 |
|
|
|
|
Branch Office Kolkata : |
4th Floor, Akash Tower, 781, Anandpur, EM Bypass, Kolkata-700107,
West Bengal, India |
|
Tel. No.: |
91-33-30909500 |
|
Telefax No.: |
91-33-30909506 |
|
|
|
|
Branch Office Chennai : |
No.6 and 7, 3rd Floor, Kasi Arcade, 116, Sir Thyagaraya
Nagar, Chennai-600017, Tamilnadu, India |
|
Tel. No.: |
91-44-43960900 |
|
Fax No.: |
91-44-43960915 |
DIRECTORS
AS ON 30.09.2013
|
Name : |
Mr. Frank Michael Wagner |
|
Designation : |
Director |
|
Address : |
Flat No-19B, Branksome Grande, No-3, Tregunter Path, Mid Levels, 0,
Hong Kong |
|
Date of Birth/Age : |
21.07.1959 |
|
Date of Appointment : |
13.03.2006 |
|
DIN No.: |
00945149 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Company/
LLP Status |
Defaulting
status |
|
1 |
U24231DL2006FTC147436 |
FRESENIUS
MEDICAL CARE INDIA PRIVATE LIMITED |
Director |
13/03/2006 |
13/03/2006 |
Active |
NO |
|
2 |
U85100DL2012PTC245524 |
SRINATH
NEPHROCARE PRIVATE LIMITED |
Nominee director |
30/11/2012 |
30/11/2012 |
Active |
NO |
|
3 |
U85191UP2013PTC058477 |
REGENCY
NEPHROCARE PRIVATE LIMITED |
Director |
19/07/2013 |
19/07/2013 |
Active |
NO |
|
Name : |
Mr. Roberto Fernandez Fuste |
|
Designation : |
Director |
|
Address : |
House No-8, Chuk Kok Village, Sai Kunk Nt, 0, Hong Kong |
|
Date of Birth/Age : |
25.01.1952 |
|
Date of Appointment : |
13.03.2006 |
|
DIN No.: |
00951680 |
|
|
|
|
Name : |
Mr. Dhruv Chaturvedi |
|
Designation : |
Director |
|
Address : |
50, 1st Floor, Habitat Floor, Jaipuria Enclave, Kaushambi,
Ghaziabad-201010, India |
|
Date of Birth/Age : |
15.10.1972 |
|
Date of Appointment : |
13.03.2006 |
|
DIN No.: |
01368390 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Company/
LLP Status |
Defaulting
status |
|
1 |
U24231DL2006FTC147436 |
FRESENIUS
MEDICAL CARE INDIA PRIVATE LIMITED |
Director |
13/03/2006 |
13/03/2006 |
Active |
NO |
|
2 |
U85100DL2012PTC245524 |
SRINATH
NEPHROCARE PRIVATE LIMITED |
Nominee director |
30/11/2012 |
30/11/2012 |
Active |
NO |
|
3 |
U85191UP2013PTC058477 |
REGENCY
NEPHROCARE PRIVATE LIMITED |
Director |
19/07/2013 |
19/07/2013 |
Active |
NO |
|
Name : |
Mr. Rakesh Mittal |
|
Designation : |
Director |
|
Address : |
D-182-A, Raj Nagar, II Palam Colony, Mangla Puri, New Delhi-110045,
India |
|
Date of Birth/Age : |
21.05.1974 |
|
Date of Appointment : |
08.03.2011 |
|
DIN No.: |
03438358 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Company/
LLP Status |
Defaulting
status |
|
1 |
U24231DL2006FTC147436 |
FRESENIUS
MEDICAL CARE INDIA PRIVATE LIMITED |
Director |
08/03/2011 |
08/03/2011 |
Active |
NO |
|
2 |
U85100DL2012PTC245524 |
SRINATH
NEPHROCARE PRIVATE LIMITED |
Nominee director |
30/11/2012 |
30/11/2012 |
Active |
NO |
|
3 |
U85191UP2013PTC058477 |
REGENCY
NEPHROCARE PRIVATE LIMITED |
Director |
19/07/2013 |
19/07/2013 |
Active |
NO |
KEY EXECUTIVES
|
Name : |
Ms. Aashima Kalra |
|
Designation : |
Secretary |
|
Address : |
Flat No.8, Maitri Appartments, Mayur Vihar, Phase-I, New Delhi-110091,
India |
|
Date of Birth/Age : |
01.10.1985 |
|
Date of Appointment : |
01.07.2010 |
|
PAN No.: |
AWSPK5658G |
|
|
|
|
Name : |
Mr. Ashwani Rohilla |
|
Designation : |
Finished Department |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 30.09.2013
|
Name
of Shareholders |
No.
of Shares |
%age |
|
Fresenius Medical Care Beteiligungsgesellschaft mbH,
Germany |
9,585,300 |
98.62 |
|
Fresenius Medical Care Deutschland GMBH, Germany |
133,800 |
1.38 |
|
TOTAL |
9,719,100 |
100.00 |
AS ON 01.10.2013
|
Name
of Allottee |
No.
of Shares |
|
Fresenius Medical Care Beteiligungsgesellschaft mbH,
Germany |
25,23,000 |
|
TOTAL |
25,23,000 |
AS ON 30.09.2013
|
Equity Shares
Break Up |
Percentage of
Holding |
|
Foreign holdings( Foreign institutional investor(s), Foreign companie(s)
Foreign financial institution(s), Non-resident Indian(s) or Overseas
Corporate bodies or Others |
100.00 |
|
TOTAL |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Trader of dialysis products |
|
|
|
|
Imports : |
|
|
Products : |
·
Dialysis products |
|
Countries : |
Germany |
|
|
|
|
Terms : |
|
|
Selling : |
Others |
|
|
|
|
Purchasing : |
Others |
GENERAL INFORMATION
|
Customers : |
Others |
|
|
|
|
No. of Employees : |
150 (Approximately) |
|
|
|
|
Bankers : |
· Deutsche Bank, Delhi, India |
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
BSR and Associates Chartered Accountant |
|
Address : |
Building No.108th Floor, Tower B, DLF Cyber City, Phase II,
India |
|
PAN No.: |
AADFB6889R |
|
|
|
|
Ultimate Holding Company : |
·
Fresenius Medical Care AG & Co., Germany |
|
|
|
|
Holding Company : |
·
Fresenius Medical Care Beteiligungsgesellscaft
mbH, Germany |
|
|
|
|
Fellow Subsidiaries : |
·
Fresenius Medical Care Phils.,Inc. ·
Fresenius Medical Care Asia Pacific Limited ·
Biocare Technology Company Limited ·
Fresenius Medical Care Technologies ·
Fresenius Medical Care Seating Pty Limited |
|
|
|
|
Subsidiaries : |
Srinath
Nephrocare Private Limited CIN No.:- U85100DL2012PTC245524 |
CAPITAL STRUCTURE
AS ON 31.03.2013
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
13300000 |
Equity Shares |
Rs.10/- each |
Rs. 133.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
9719100 |
Equity Shares |
Rs.10/- each |
Rs. 97.191
Millions |
|
|
|
|
|
AS ON 30.09.2013
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
13300000 |
Equity Shares |
Rs.10/- each |
Rs. 133.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
12242100 |
Equity Shares |
Rs.10/- each |
Rs. 122.421
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES
OF FUNDS |
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
|
|
|
|
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
97.191 |
88.380 |
88.380 |
|
(b) Reserves & Surplus |
271.105 |
206.675 |
188.961 |
|
(c) Money received against
share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
368.296 |
295.055 |
277.341 |
|
|
|
|
|
|
(3) Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
8.237 |
3.312 |
0.000 |
|
(b) Deferred tax liabilities
(Net) |
2.471 |
5.845 |
1.489 |
|
(c) Other long term
liabilities |
12.087 |
8.490 |
4.271 |
|
(d) long-term provisions |
0.000 |
0.000 |
3.667 |
|
Total
Non-current Liabilities (3) |
22.795 |
17.647 |
9.427 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
0.000 |
0.000 |
0.000 |
|
(b) Trade payables |
613.685 |
375.337 |
256.993 |
|
(c) Other current liabilities |
61.864 |
36.888 |
17.420 |
|
(d) Short-term provisions |
13.055 |
4.981 |
6.587 |
|
Total
Current Liabilities (4) |
688.604 |
417.206 |
281.000 |
|
|
|
|
|
|
TOTAL |
1,079.695 |
729.908 |
567.768 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
156.701 |
99.605 |
69.607 |
|
(ii) Intangible Assets |
3.284 |
5.106 |
4.355 |
|
(iii) Capital work-in-progress |
0.416 |
10.633 |
1.942 |
|
(iv) Intangible assets under
development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
8.811 |
0.000 |
0.000 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
16.743 |
10.052 |
7.719 |
|
(e) Other Non-current assets |
1.542 |
0.000 |
0.000 |
|
Total
Non-Current Assets |
187.497 |
125.396 |
83.623 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
0.000 |
0.000 |
0.000 |
|
(b) Inventories |
427.659 |
301.441 |
237.855 |
|
(c) Trade receivables |
353.597 |
219.986 |
145.690 |
|
(d) Cash and cash equivalents |
97.425 |
73.685 |
93.771 |
|
(e) Short-term loans and
advances |
10.159 |
6.534 |
6.829 |
|
(f) Other current assets |
3.358 |
2.866 |
0.000 |
|
Total
Current Assets |
892.198 |
604.512 |
484.145 |
|
|
|
|
|
|
TOTAL |
1,079.695 |
729.908 |
567.768 |
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
|
SALES |
|
|
|
|
|
Income |
1,812.995 |
1274.889 |
998.916 |
|
|
Other Income |
2.476 |
0.760 |
0.000 |
|
|
TOTAL
|
1,815.471 |
1,275.649 |
998.916 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Cost of Goods Sold |
|
|
831.864 |
|
|
Manufacturing Expenses |
|
|
|
|
|
Marketing and Service Expenses |
|
|
|
|
|
TOTAL
|
1,687.608 |
1,227.816 |
831.864 |
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
127.863 |
47.833 |
167.052 |
|
|
|
|
|
|
|
Less/
Add |
DEPRECIATION/
AMORTISATION |
29.488 |
20.822 |
13.021 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX |
98.375 |
27.011 |
154.031 |
|
|
|
|
|
|
|
Less |
TAX |
33.945 |
9.297 |
52.318 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) AFTER TAX |
64.430 |
17.714 |
101.713 |
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
308.388 |
290.674 |
188.961 |
|
|
|
|
|
|
|
|
Balance
Carried to the B/S |
372.818 |
308.388 |
290.674 |
|
|
|
|
|
|
|
|
EARNINGS
IN FOREIGN CURRENCY |
|
|
|
|
|
F.O.B. Value of Exports |
154.967 |
118.578 |
66.183 |
|
|
TOTAL
EARNINGS |
154.967 |
118.578 |
66.183 |
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
Raw Materials |
13.763 |
13.763 |
NA |
|
|
TOTAL
IMPORTS |
13.763 |
13.763 |
NA |
|
|
|
|
|
|
|
|
Earnings
/ (Loss) Per Share (Rs.) |
6.63 |
-- |
-- |
KEY RATIOS
|
PARTICULARS |
|
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
|
PAT / Total Income |
(%) |
3.55 |
1.39 |
10.18 |
|
|
|
|
|
|
|
|
|
Net Profit Margin |
(%) |
5.43 |
2.70 |
15.42 |
|
|
|
|
|
|
|
|
|
Return on Total Assets |
(%) |
9.19 |
3.76 |
27.22 |
|
|
|
|
|
|
|
|
|
Return on Investment (ROI) |
|
0.27 |
0.09 |
0.56 |
|
|
|
|
|
|
|
|
|
Debt Equity Ratio |
|
0.02 |
0.01 |
0.00 |
|
|
|
|
|
|
|
|
|
Current Ratio |
|
1.30 |
1.45 |
1.72 |
|
FINANCIAL ANALYSIS
[all figures are
in Rupees Millions]
DEBT EQUITY RATIO
|
Particular |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(INR
in Mlns.) |
(INR
in Mlns.) |
(INR
in Mlns.) |
|
Share Capital |
88.380 |
88.380 |
97.191 |
|
Reserves & Surplus |
188.961 |
206.675 |
271.105 |
|
Net
worth |
277.341 |
295.055 |
368.296 |
|
|
|
|
|
|
long-term borrowings |
0.000 |
3.312 |
8.237 |
|
Short term borrowings |
0.000 |
0.000 |
0.000 |
|
Total
borrowings |
0.000 |
3.312 |
8.237 |
|
Debt/Equity
ratio |
0.000 |
0.011 |
0.022 |
YEAR ON YEAR GROWTH
|
Year
on Year Growth |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(INR
in Mlns) |
(INR
in Mlns) |
(INR
in Mlns) |
|
Sales |
998.916 |
1,274.889 |
1,812.995 |
|
|
|
27.627 |
42.208 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(INR) |
(INR) |
(INR) |
|
Sales |
998.916 |
1,274.889 |
1,812.995 |
|
Profit |
101.713 |
17.714 |
64.430 |
|
|
10.18% |
1.39% |
3.55% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
Yes |
|
9] |
Name of person contacted |
Yes |
|
10] |
Designation of contact
person |
Yes |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
----- |
|
14] |
Estimation for coming
financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
Yes |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
Yes |
|
20] |
Export / Import details (if
applicable) |
Yes |
|
21] |
Market information |
----- |
|
22] |
Litigations that the firm
/ promoter involved in |
----- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking
account |
----- |
|
26] |
Buyer visit details |
----- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
Yes |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth of Proprietor/Partner/Director,
if available |
Yes |
|
32] |
PAN of
Proprietor/Partner/Director, if available |
No |
|
33] |
Voter ID No of
Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating,
if available |
No |
INDEX OF CHARGES -
No Charges Exist for Company
NOTE
Registered office has been shifted from 11th Floor, Gopal
Dass Tower, Barakhamba Road, Connaught Place, New Delhi-110001, India to the
present address w.e.f. 12.11.2012.
BACKGROUND
Subject is a
company, incorporated on 13 March 2006 and the main object of the business is a
provider of products and services for the health care industry and for
individuals undergoing dialysis.
FIXED ASSETS
·
Furniture and Fixtures
·
Motor Vehicles
·
Office Equipments
·
Plant and Equipment
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 59.06 |
|
|
1 |
Rs. 99.34 |
|
Euro |
1 |
Rs. 80.61 |
INFORMATION DETAILS
|
Information Gathered
by : |
PDT |
|
|
|
|
Analysis Done by
: |
KRN |
|
|
|
|
Report Prepared
by : |
DPT |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
6 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
47 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.